Access Now: AORN COVID-19 Clinical Support

Home >  News >  October, 2008

FDA Issues Surgical Mesh Warning

Agency has received reports of complications following two commonly performed GYN procedures.

Published: October 24, 2008

Surgical mesh used to treat pelvic organ prolapse and stress urinary incontinence can cause severe complications when placed through incisions in the vagina, according to a warning issued by the Food and Drug Administration. Potential complications include erosion of the vagina’s wall, infection, pain, urinary problems and recurrence of the prolapse or incontinence.

The FDA has also received reports of mesh erosion causing scarring of the vagina, which led to discomfort and pain during sexual intercourse and required additional surgery to remove mesh that had eroded into the vagina.

Daniel Cook

Also in the News...

Hospitals Increasing Investments in ASCs
ASCs Provided Safe Surgical Care as Pandemic Spread
Hospital CEO Resigns After Making Incision During Surgery
Roadmap for Performing Surgery During COVID-19
Physicians Denounce 2021 CMS Fee Schedule
Nominate Your Facility for an OR Excellence Award
Physicians Tepid About Telehealth

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

Did You See This?

advertiser banner

Other Articles That May Interest You